Jones Financial Companies Lllp grew its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 45.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,101 shares of the company's stock after acquiring an additional 11,886 shares during the period. Jones Financial Companies Lllp's holdings in Bath & Body Works were worth $1,477,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. SRS Capital Advisors Inc. boosted its holdings in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after acquiring an additional 329 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Bath & Body Works by 135.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after purchasing an additional 582 shares during the last quarter. QRG Capital Management Inc. boosted its stake in shares of Bath & Body Works by 14.8% in the 4th quarter. QRG Capital Management Inc. now owns 54,473 shares of the company's stock valued at $2,112,000 after purchasing an additional 7,025 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $1,378,000. Finally, Oppenheimer Asset Management Inc. raised its stake in shares of Bath & Body Works by 1.2% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 52,355 shares of the company's stock worth $2,030,000 after buying an additional 604 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
BBWI has been the subject of a number of analyst reports. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Cowen reaffirmed a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. TD Cowen increased their target price on Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a research note on Thursday, December 12th. Telsey Advisory Group restated an "outperform" rating and set a $43.00 target price on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Argus reiterated a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $45.06.
Get Our Latest Stock Analysis on BBWI
Bath & Body Works Stock Down 2.3 %
Shares of NYSE:BBWI traded down $0.71 during mid-day trading on Tuesday, reaching $29.75. 6,502,230 shares of the stock were exchanged, compared to its average volume of 4,037,949. The company has a market cap of $6.44 billion, a P/E ratio of 7.26, a P/E/G ratio of 0.92 and a beta of 1.89. The stock's 50 day simple moving average is $37.09 and its 200-day simple moving average is $34.14. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works announced that its board has initiated a stock repurchase program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 6.4% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its stock is undervalued.
Bath & Body Works Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were paid a dividend of $0.20 per share. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.69%. Bath & Body Works's dividend payout ratio is 21.98%.
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.